Medicare Enrolled
Dr. Stanislav Goykhman, M.D
Internal Medicine · Lyndhurst, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goykhman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goykhman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goykhman
Dr. Stanislav Goykhman is an internal medicine specialist in Lyndhurst, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Goykhman performed 2,183 Medicare services across 1,090 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goykhman received a total of $241,674 from 75 pharmaceutical and/or device companies across 1769 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goykhman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in NJ
$241,674 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,183
Medicare services
Top 20% in NJ for internal medicine
1,090
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,553 | $98 | $513 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
169 | $4 | $18 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
150 | $27 | $147 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $65 | $386 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $133 | $688 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
34 | $12 | $64 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
18 | $107 | $613 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $34 | $106 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
11 | $72 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$241,674
Total received (2018-2024)
Avg $34,525/year across 7 years
Top 0% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,769
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$226,809 (93.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,006 (5.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,859 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$49,021
2023
$31,180
2022
$17,508
2021
$21,303
2020
$46,186
2019
$55,299
2018
$21,178
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$30,056
Dexcom, Inc.
$9,506
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,670
Novo Nordisk Inc
$272
AstraZeneca Pharmaceuticals LP
$199
Insulet Corporation
$189
Amgen Inc.
$147
SANOFI-AVENTIS U.S. LLC
$108
Abbott Laboratories
$108
Xeris Pharmaceuticals, Inc.
$106
Amneal Pharmaceuticals LLC
$92
ABBVIE INC.
$66
Corcept Therapeutics
$61
Radius Health, Inc.
$56
CeQur Corporation
$49
Tandem Diabetes Care, Inc.
$35
Antares Pharma, Inc.
$32
Verity Pharmaceuticals Inc.
$31
Embecta Corp.
$30
Echosens North America, Inc.
$23
PFIZER INC.
$21
Alexion Pharmaceuticals, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
Neurocrine Biosciences, Inc.
$17
Tolmar, Inc.
$17
Esperion Therapeutics, Inc.
$17
Amphastar Pharmaceuticals, Inc.
$17
Azurity Pharmaceuticals, Inc.
$16
Novartis Pharmaceuticals Corporation
$15
Currax Pharmaceuticals LLC
$15
RECORDATI_RARE_DISEASES_INC.
$13
Top 3 companies account for 96.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$79,456
AstraZeneca Pharmaceuticals LP
$48,342
Lilly USA, LLC
$45,956
Dexcom, Inc.
$25,126
Amarin Pharma Inc.
$21,226
Merck Sharp & Dohme Corporation
$6,494
Novo Nordisk Inc
$4,137
SANOFI-AVENTIS U.S. LLC
$1,592
Medtronic MiniMed, Inc.
$1,514
Amgen Inc.
$686
Corcept Therapeutics
$683
Novo Nordisk AS
$580
Insulet Corporation
$542
Amneal Pharmaceuticals LLC
$444
Tandem Diabetes Care, Inc.
$435
Medtronic, Inc.
$424
Mannkind Corporation
$327
Abbott Laboratories
$293
Xeris Pharmaceuticals, Inc.
$277
MannKind Corporation
$225
Bayer Healthcare Pharmaceuticals Inc.
$192
Antares Pharma, Inc.
$180
Radius Health, Inc.
$146
Merck Sharp & Dohme LLC
$130
CeQur Corporation
$126
DEXCOM, INC.
$113
ABBVIE INC.
$110
Janssen Pharmaceuticals, Inc
$109
EISAI INC.
$108
AbbVie Inc.
$90
GENZYME CORPORATION
$86
Shire North American Group Inc
$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$76
Alexion Pharmaceuticals, Inc.
$73
PFIZER INC.
$66
Becton, Dickinson and Company
$59
TOPCON HEALTHCARE SOLUTIONS, INC.
$58
Esperion Therapeutics, Inc.
$58
VistaPharm, Inc.
$56
AbbVie, Inc.
$53
Amryt Pharma Holdings Ltd
$51
RECORDATI_RARE_DISEASES_INC.
$47
Zealand Pharma US, Inc.
$44
Embecta Corp.
$44
Clarus Therapeutics Inc.
$44
Regeneron Healthcare Solutions, Inc.
$41
Novartis Pharmaceuticals Corporation
$41
IBSA Pharma Inc.
$40
Supernus Pharmaceuticals, Inc.
$36
Amphastar Pharmaceuticals, Inc.
$34
Azurity Pharmaceuticals, Inc.
$34
Horizon Therapeutics plc
$31
Verity Pharmaceuticals Inc.
$31
VIVUS, Inc.
$31
Rhythm Pharmaceuticals, Inc.
$28
Kowa Pharmaceuticals America, Inc.
$28
Valeritas, Inc.
$27
CMP Pharma, Inc.
$27
Eisai Inc.
$26
GlaxoSmithKline, LLC.
$25
Echosens North America, Inc.
$23
Ultragenyx Pharmaceutical Inc.
$20
Neurocrine Biosciences, Inc.
$17
Tolmar, Inc.
$17
Axsome Therapeutics, Inc.
$16
Hikma Pharmaceuticals USA
$16
Lundbeck LLC
$16
Intuity Medical Inc
$15
SANOFI PASTEUR INC.
$15
Intercept Pharmaceuticals, Inc.
$15
Currax Pharmaceuticals LLC
$15
Lupin Inc.
$14
LifeScan, Inc.
$14
Gilead Sciences, Inc.
$13
Senseonics, Incorporated
$12
Top 3 companies account for 71.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · Aimovig · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · Belviq · CERDELGA · CONTRAVE · CREON · CYCLOSET · Carospir · CeQur Simplicity · Creon · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · EMGALITY · EVENITY · Eversense · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HARMONY · HORIZANT · HUMALOG · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · LYUMJEV · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Norditropin · OCALIVA · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · REXULTI · RYBELSUS · Repatha · Ryaltris · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SOMAVERT · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Sogroya · Strensiq · Sunosi · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
10,833
Per 100K population
1134.7
County median income
$123,715
Nearest hospital
CLARA MAASS MEDICAL CENTER
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goykhman is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NJ), with speaking/promotional industry engagement in the top 0% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goykhman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Goykhman performed 1,553 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goykhman receive payments from pharmaceutical companies?
Yes. Dr. Goykhman received a total of $241,674 from 75 companies across 1,769 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goykhman's costs compare to other internal medicine physicians in Lyndhurst?
Dr. Goykhman's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goykhman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lyndhurst
Browse internal medicine physicians in Lyndhurst ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology